Biotech | April 25, 2022
New studies presented at ECCMIC 2022 confirm benefit of remdesivir in treating Covid-19
Real-world evidence from more than 850,000 hospitalized patients provides clinical insights on the use of Veklury (remdesivir) as stand of care Covid-19 treatment
